The global in vitro diagnostics market is estimated at USD 82.5 billion in 2023 and is projected to reach USD 117.1 billion by 2030, expected to grow at a CAGR of 5.1% during the forecast period, 2024 ...
The global in vitro diagnostics market (IVD) was valued at $67,111 million in 2019, and is projected to reach $91,093 million at a CAGR of 4.8% from 2020 to 2027. For instance, in clinical chemistry ...
19h
News-Medical.Net on MSNTecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kitsTecan Group today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics ...
Dublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis ...
Next-Generation Sequencing and POC Testing Transform IVD Accuracy and SpeedDublin, March 28, 2025 (GLOBE NEWSWIRE) -- The "In-Vitro Diagnostic Market - North America and Country Analysis: Focus on ...
RFK Jr. should accept the ruling and instruct the agency to immediately halt all efforts to regulate laboratory-developed and ...
Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing, with a rapidly developing presence in highly specialised and molecular clinical diagnostics testing and in-vitro ...
The US Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women.
Fierce Electronics proudly announces the fourth group of honorees in the inaugural 40 Under 40 awards program. These awards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results